Leukeran for LymphomaLymphoma occurs when lymphocytes (white blood cells of the lymphatic system) become abnormal and begin to grow and divide without control or order. The lymphatic system includes lymph nodes, bone marrow, and the spleen. In addition, lymphatic tissue is found in other parts of the body, including the skin. Lymphoma can start almost anywhere lymphatic tissue is present.
There are two main types of lymphoma:
- Non-Hodgkin's lymphoma
- Hodgkin's lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell.
Both types of lymphoma include a large, diverse group of cancers.
Leukeran is approved to treat non-Hodgkin's and Hodgkin's lymphoma. Leukeran will not cure lymphoma, but may be useful in reducing symptoms.
How Does It Work?Leukeran belongs to a group of medicines known as alkylating agents. It works by interfering with DNA replication, which is a process necessary for cells to copy themselves and divide. This causes cell death. The medication also activates a protein that causes cell death by a process known as apoptosis.
While Leukeran can kill both healthy and cancerous cells, it has a greater effect on cells that are multiplying rapidly. Generally, cancer cells multiply more rapidly than healthy cells and are, therefore, more affected by Leukeran.